BREAKING: 9 of the largest US and European-based drugmakers have signed a deal with President Trump to lower drug prices and avoid tariffs. The list includes: Merck, Bristol Myers Squibb, Amgen, Gilead, GSK, Sanofi, Roche’s Genentech, Boehringer Ingelheim, and Novartis.(The Kobeissi Letter)